Détention brevets de la classe A61K 31/56

Brevets de cette classe: 2923

Historique des publications depuis 10 ans

232
229
212
198
212
216
138
128
119
61
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
The Regents of the University of California
19898
58
Sage Therapeutics, Inc.
365
29
The Johns Hopkins University
5667
27
Mexichem Fluor, Sociedad Anonima de Capital Variable
203
22
Brigham Young University
598
21
InterCept Pharmaceuticals, Inc.
207
20
Ellodi Pharmaceuticals, L.P., General Partner, Ellodi Development I Genpar, LLC, a Delaware limited liability company
27
20
Lipocine Inc.
112
19
Reata Pharmaceuticals, Inc.
123
19
Emory University
1626
18
Corcept Therapeutics, Inc.
338
17
Laboratoire Hra-pharma
150
16
Arven Ilac Sanayi Ve Ticaret A.S.
96
15
Phoenix Biotechnology, Inc.
50
15
Enanta Pharmaceuticals, Inc.
428
14
Alcon, Inc.
5418
13
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
823
13
Board of Regents, The University of Texas System
5786
12
Royalty Security, LLC
24
12
California Institute of Technology
3974
11
Autres propriétaires 2532